REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Amerise Biosciences Ltd. (India)

Main Activities: Commodity Contracts Brokerage
Full name: Amerise Biosciences Ltd. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Amerise Biosciences Ltd. is based in India, with the head office in Ahmedabad. It operates in the Commodity Contracts Brokerage industry. The company was established on 1984.

Legal Address
24, Laxmi Chambers,, , Navjeevan Press Road
Ahmedabad; Gujarat; Postal Code: 380014

Contact Details: Purchase the Amerise Biosciences Ltd. report to view the information.

Website: http://www.amradeepindustries.in

Basic Information
Outstanding Shares:
Purchase the Amerise Biosciences Ltd. report to view the information.
Registered Capital:
Purchase the Amerise Biosciences Ltd. report to view the information.
Financial Auditors:
Purchase the Amerise Biosciences Ltd. report to view the information.
Incorporation Date:
1984
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
WholeTime Director & CFO
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
72.07%
Purchase this report to view the information.
27.93%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Amerise Biosciences Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
26.1%▲
Net Profit (Loss) for the Period
26.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo